New HIV diagnoses in patients with COVID-19: two case reports and a brief literature review

go back to reference World Health Organization (WHO). Coronavirus disease (COVID-2019) situation reports. https://www.who.int/emergencies/diseases/novel-coronavirus-2019/situation-reports. Accessed April 21, 2020. World Health Organization (WHO). Coronavirus disease (COVID-2019) situation reports. https://​www.​who.​int/​emergencies/​diseases/​novel-coronavirus-2019/​situation-reports. Accessed April 21, 2020.

go back to reference Mirzaei H, McFarland W, Karamouzian M, Sharifi H. COVID-19 among people living with HIV: a systematic review. AIDS Behav. 2020:1–8. Mirzaei H, McFarland W, Karamouzian M, Sharifi H. COVID-19 among people living with HIV: a systematic review. AIDS Behav. 2020:1–8.

go back to reference Chan JF, Yuan S, Kok KH, To KK, Chu H, Yang J, Xing F, Liu J, Yip CC, Poon RW, Tsoi HW, Lo SK, Chan KH, Poon VK, Chan WM, Ip JD, Cai JP, Cheng VC, Chen H, Hui CK, Yuen KY. A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster. Lancet. 2020;395(10223):514–23.CrossRefPubMed Chan JF, Yuan S, Kok KH, To KK, Chu H, Yang J, Xing F, Liu J, Yip CC, Poon RW, Tsoi HW, Lo SK, Chan KH, Poon VK, Chan WM, Ip JD, Cai JP, Cheng VC, Chen H, Hui CK, Yuen KY. A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster. Lancet. 2020;395(10223):514–23.CrossRefPubMed

go back to reference Zhang JC, Zhang HJ, Li Y, Jing D, Liu Q, Zhao K, Liu QQ, Zhuang Y, Kang WZ, Sun YT. Changes in levels of T cell subpopulations to monitor the response to antiretroviral therapy among HIV-1-infected patients during two years of HIV-1 replication suppression. Scand J Infect Dis. 2013;45(5):368–77.CrossRefPubMed Zhang JC, Zhang HJ, Li Y, Jing D, Liu Q, Zhao K, Liu QQ, Zhuang Y, Kang WZ, Sun YT. Changes in levels of T cell subpopulations to monitor the response to antiretroviral therapy among HIV-1-infected patients during two years of HIV-1 replication suppression. Scand J Infect Dis. 2013;45(5):368–77.CrossRefPubMed

go back to reference Burchell AN, Allen VG, Gardner SL, Moravan V, Tan DH, Grewal R, Raboud J, Bayoumi AM, Kaul R, Mazzulli T, McGee F, Rourke SB. OHTN cohort study team. High incidence of diagnosis with syphilis co-infection among men who have sex with men in an HIV cohort in Ontario, Canada. BMC Infect Dis. 2015;15:356.CrossRefPubMed Burchell AN, Allen VG, Gardner SL, Moravan V, Tan DH, Grewal R, Raboud J, Bayoumi AM, Kaul R, Mazzulli T, McGee F, Rourke SB. OHTN cohort study team. High incidence of diagnosis with syphilis co-infection among men who have sex with men in an HIV cohort in Ontario, Canada. BMC Infect Dis. 2015;15:356.CrossRefPubMed

go back to reference Bozicevic I, Lepej SZ, Rode OD, Grgic I, Jankovic P, Dominkovic Z, Lukas D, Johnston LG, Begovac J. Prevalence of HIV and sexually transmitted infections and patterns of recent HIV testing among men who have sex with men in Zagreb, Croatia. Sex Transm Infect. 2012;88(7):539–44.CrossRefPubMed Bozicevic I, Lepej SZ, Rode OD, Grgic I, Jankovic P, Dominkovic Z, Lukas D, Johnston LG, Begovac J. Prevalence of HIV and sexually transmitted infections and patterns of recent HIV testing among men who have sex with men in Zagreb, Croatia. Sex Transm Infect. 2012;88(7):539–44.CrossRefPubMed

go back to reference Chen G, Wu D, Guo W, Cao Y, Huang D, Wang H, Wang T, Zhang X, Chen H, Yu H, Zhang X, Zhang M, Wu S, Song J, Chen T, Han M, Li S, Luo X, Zhao J, Ning Q. Clinical and immunological features of severe and moderate coronavirus disease 2019. J Clin Invest. 2020;130(5):2620–9.CrossRefPubMed Chen G, Wu D, Guo W, Cao Y, Huang D, Wang H, Wang T, Zhang X, Chen H, Yu H, Zhang X, Zhang M, Wu S, Song J, Chen T, Han M, Li S, Luo X, Zhao J, Ning Q. Clinical and immunological features of severe and moderate coronavirus disease 2019. J Clin Invest. 2020;130(5):2620–9.CrossRefPubMed

go back to reference Kanwugu ON, Adadi P. HIV/SARS-CoV-2 coinfection: a global perspective. J Med Virol. 2020. https://doi.org/10.1002/jmv.26321 Online ahead of print. Kanwugu ON, Adadi P. HIV/SARS-CoV-2 coinfection: a global perspective. J Med Virol. 2020. https://​doi.​org/​10.​1002/​jmv.​26321 Online ahead of print.

go back to reference Blanco JL, Ambrosioni J, Garcia F, Martínez E, Soriano A, Mallolas J, Miro JM. COVID-19 in HIV investigators. COVID-19 in patients with HIV: clinical case series. Lancet HIV. 2020;7:e314–6.CrossRefPubMed Blanco JL, Ambrosioni J, Garcia F, Martínez E, Soriano A, Mallolas J, Miro JM. COVID-19 in HIV investigators. COVID-19 in patients with HIV: clinical case series. Lancet HIV. 2020;7:e314–6.CrossRefPubMed

go back to reference Altuntas Aydin O, Kumbasar Karaosmanoglu H, Kart Yasar K. HIV/SARS-CoV-2 coinfected patients in Istanbul, Turkey. J Med Virol. 2020. https://doi.org/10.1002/jmv.25955. Online ahead of print. Altuntas Aydin O, Kumbasar Karaosmanoglu H, Kart Yasar K. HIV/SARS-CoV-2 coinfected patients in Istanbul, Turkey. J Med Virol. 2020. https://​doi.​org/​10.​1002/​jmv.​25955. Online ahead of print.

go back to reference Gervasoni C, Meraviglia P, Riva A, Giacomelli A, Oreni L, Minisci D, Atzori C, Ridolfo A, Cattaneo D. Clinical features and outcomes of HIV patients with coronavirus disease 2019. Clin Infect Dis. 2020. https://doi.org/10.1093/cid/ciaa579. Online ahead of print. Gervasoni C, Meraviglia P, Riva A, Giacomelli A, Oreni L, Minisci D, Atzori C, Ridolfo A, Cattaneo D. Clinical features and outcomes of HIV patients with coronavirus disease 2019. Clin Infect Dis. 2020. https://​doi.​org/​10.​1093/​cid/​ciaa579. Online ahead of print.

go back to reference Mascolo S, Romanelli A, Carleo MA, Esposito V. Could HIV infection alter the clinical course of SARS-CoV-2 infection? When less is better. J Med Virol. 2020. https://doi.org/10.1002/jmv.25881. Online ahead of print. Mascolo S, Romanelli A, Carleo MA, Esposito V. Could HIV infection alter the clinical course of SARS-CoV-2 infection? When less is better. J Med Virol. 2020. https://​doi.​org/​10.​1002/​jmv.​25881. Online ahead of print.

go back to reference Marimuthu J, Kumar BS, Aravind GP. HIV and SARS CoV-2 co-infection: A retrospective, record based, case series from South India. J Med Virol. 2020. https://doi.org/10.1002/jmv.26271. Marimuthu J, Kumar BS, Aravind GP. HIV and SARS CoV-2 co-infection: A retrospective, record based, case series from South India. J Med Virol. 2020. https://​doi.​org/​10.​1002/​jmv.​26271.

go back to reference Suwanwongse K, Shabarek N. Clinical features and outcome of HIV/SARS-CoV-2 coinfected patients in The Bronx, New York city. J Med Virol. 2020. p. 28. https://doi.org/10.1002/jmv.26077. Online ahead of print. Suwanwongse K, Shabarek N. Clinical features and outcome of HIV/SARS-CoV-2 coinfected patients in The Bronx, New York city. J Med Virol. 2020. p. 28. https://​doi.​org/​10.​1002/​jmv.​26077. Online ahead of print.

go back to reference Maggiolo F, Zoboli F, Arosio M, Valenti D, Guarneri D, Sangiorgio L, Ripamonti D, Callegaro A. SARS-CoV-2 infection in persons living with HIV: a single center prospective cohort. J Med Virol. 2020. https://doi.org/10.1002/jmv.26352. Maggiolo F, Zoboli F, Arosio M, Valenti D, Guarneri D, Sangiorgio L, Ripamonti D, Callegaro A. SARS-CoV-2 infection in persons living with HIV: a single center prospective cohort. J Med Virol. 2020. https://​doi.​org/​10.​1002/​jmv.​26352.

go back to reference Ruan L, Zhang Y, Luo Y, Yu X, Zeng Y, Peng H, Han L, Chen L, Roy S, Cheng Q, Li H, Guo X, Xiong D, Gan H, Liu M. Clinical features and outcomes of four HIV patients with COVID-19 in Wuhan, China. J Med Virol. 2020. https://doi.org/10.1002/jmv.26223. Ruan L, Zhang Y, Luo Y, Yu X, Zeng Y, Peng H, Han L, Chen L, Roy S, Cheng Q, Li H, Guo X, Xiong D, Gan H, Liu M. Clinical features and outcomes of four HIV patients with COVID-19 in Wuhan, China. J Med Virol. 2020. https://​doi.​org/​10.​1002/​jmv.​26223.

go back to reference Vizcarra P, Perez-Elias MJ, Quereda C, Quereda C, Moreno A, Vivancos M, Dronda F, Casado J. Description of COVID-19 in HIV-infected individuals: a single-centre, prospective cohort. Lancet HIV. 2020;7(8):e554–64. https://doi.org/10.1016/S2352-3018(20)30164-8. Epub 2020 May 28. Vizcarra P, Perez-Elias MJ, Quereda C, Quereda C, Moreno A, Vivancos M, Dronda F, Casado J. Description of COVID-19 in HIV-infected individuals: a single-centre, prospective cohort. Lancet HIV. 2020;7(8):e554–64. https://​doi.​org/​10.​1016/​S2352-3018(20)30164-8. Epub 2020 May 28.

go back to reference Cooper TJ, Woodward BL, Alom S, Harky A. Coronavirus disease 2019 (COVID-19) outcomes in HIV_AIDS patients a systematic review. HIV Med. 2020. https://doi.org/10.1111/hiv.12911. Cooper TJ, Woodward BL, Alom S, Harky A. Coronavirus disease 2019 (COVID-19) outcomes in HIV_AIDS patients a systematic review. HIV Med. 2020. https://​doi.​org/​10.​1111/​hiv.​12911.

go back to reference Mang S, Kaddu-Mulindwa D, Metz C, Becker A, Seiler F, Smola S, Maßmann A, Becker SL, Papan C, Bals R, Lepper PM, Danziger G. Pneumocystis Jirovecii Pneumonia and SARS-CoV-2 Co-Infection in newly diagnosed HIV-1 infection. Clin Infect Dis. 2020. p. ciaa906. https://doi.org/10.1093/cid/ciaa906. Online ahead of print. Mang S, Kaddu-Mulindwa D, Metz C, Becker A, Seiler F, Smola S, Maßmann A, Becker SL, Papan C, Bals R, Lepper PM, Danziger G. Pneumocystis Jirovecii Pneumonia and SARS-CoV-2 Co-Infection in newly diagnosed HIV-1 infection. Clin Infect Dis. 2020. p. ciaa906. https://​doi.​org/​10.​1093/​cid/​ciaa906. Online ahead of print.

go back to reference Cillóniz C, García-Vidal C, Moreno A, Miro J, Torres A. Community-acquired bacterial pneumonia in adult HIV infected patients. Expert Rev Anti-Infect Ther. 2018;16(7):579–88.CrossRef Cillóniz C, García-Vidal C, Moreno A, Miro J, Torres A. Community-acquired bacterial pneumonia in adult HIV infected patients. Expert Rev Anti-Infect Ther. 2018;16(7):579–88.CrossRef

go back to reference Zhang Q, Wang Y, Qi C, Shen L, Li J. Clinical trial analysis of 2019-nCoV therapy registered in China. J Med Virol. 2020;92(6):540–5. https://doi.org/10.1002/jmv.25733. Epub 2020 Mar 5. Zhang Q, Wang Y, Qi C, Shen L, Li J. Clinical trial analysis of 2019-nCoV therapy registered in China. J Med Virol. 2020;92(6):540–5. https://​doi.​org/​10.​1002/​jmv.​25733. Epub 2020 Mar 5.

go back to reference Zhang C, Wu Z, Li JW, Zhao H, Wang GQ. The cytokine release syndrome (CRS) of severe COVID-19 and Interleukin-6 receptor (IL-6R) antagonist Tocilizumab may be the key to reduce the mortality. Int J Antimicrob Agents. 2020;55(5):105954 Epub 2020 Mar 29.CrossRefPubMed Zhang C, Wu Z, Li JW, Zhao H, Wang GQ. The cytokine release syndrome (CRS) of severe COVID-19 and Interleukin-6 receptor (IL-6R) antagonist Tocilizumab may be the key to reduce the mortality. Int J Antimicrob Agents. 2020;55(5):105954 Epub 2020 Mar 29.CrossRefPubMed

go back to reference Fu B, Xu X, Wei H. Why tocilizumab could be an effective treatment for severe COVID-19? J Transl Med. 2020;18(1):164.CrossRefPubMed Fu B, Xu X, Wei H. Why tocilizumab could be an effective treatment for severe COVID-19? J Transl Med. 2020;18(1):164.CrossRefPubMed

go back to reference Luo P, Liu Y, Qiu L, Liu X, Liu D, Li J. Tocilizumab treatment in COVID-19: a single center experience. J Med Virol. 2020;92(7):814–8 Epub 2020 Apr 15.CrossRef Luo P, Liu Y, Qiu L, Liu X, Liu D, Li J. Tocilizumab treatment in COVID-19: a single center experience. J Med Virol. 2020;92(7):814–8 Epub 2020 Apr 15.CrossRef

go back to reference Zhang C, Wu Z, Li JW, Zhao H, Wang GQ. Cytokine release syndrome in severe COVID-19: interleukin-6 receptor antagonist tocilizumab may be the key to reduce mortality. Int J Antimicrob Agents. 2020;55(5):105954 Epub 2020 Mar 29.CrossRefPubMed Zhang C, Wu Z, Li JW, Zhao H, Wang GQ. Cytokine release syndrome in severe COVID-19: interleukin-6 receptor antagonist tocilizumab may be the key to reduce mortality. Int J Antimicrob Agents. 2020;55(5):105954 Epub 2020 Mar 29.CrossRefPubMed

go back to reference Xu X, Han M, Li T, Sun W, Wang D, Fu B, Zhou Y, Zheng X, Yang Y, Li X, Zhang X, Pan A, Wei H. Effective treatment of severe COVID-19 patients with tocilizumab. Proc Natl Acad Sci U S A. 2020;117(20):10970–5 Epub 2020 Apr 29.CrossRefPubMed Xu X, Han M, Li T, Sun W, Wang D, Fu B, Zhou Y, Zheng X, Yang Y, Li X, Zhang X, Pan A, Wei H. Effective treatment of severe COVID-19 patients with tocilizumab. Proc Natl Acad Sci U S A. 2020;117(20):10970–5 Epub 2020 Apr 29.CrossRefPubMed

go back to reference Toniati P, Piva S, Cattalini M, Garrafa E, Regola F, Castelli F, Franceschini F, Airò P, Bazzani C, Beindorf EA, Berlendis M, Bezzi M, Bossini N, Castellano M, Cattaneo S, Cavazzana I, Contessi GB, Crippa M, Delbarba A, De Peri E, Faletti A, Filippini M, Filippini M, Frassi M, Gaggiotti M, Gorla R, Lanspa M, Lorenzotti S, Marino R, Maroldi R, Metra M, Matteelli A, Modina D, Moioli G, Montani G, Muiesan ML, Odolini S, Peli E, Pesenti S, Pezzoli MC, Pirola I, Pozzi A, Proto A, Rasulo FA, Renisi G, Ricci C, Rizzoni D, Romanelli G, Rossi M, Salvetti M, Scolari F, Signorini L, Taglietti M, Tomasoni G, Tomasoni LR, Turla F, Valsecchi A, Zani D, Zuccalà F, Zunica F, Focà E, Andreoli L, Latronico N. Tocilizumab for the treatment of severe COVID-19 pneumonia with hyperinflammatory syndrome and acute respiratory failure: a single center study of 100 patients in Brescia, Italy. Autoimmun Rev. 2020;19(7):102568 Epub 2020 May 3.CrossRefPubMed Toniati P, Piva S, Cattalini M, Garrafa E, Regola F, Castelli F, Franceschini F, Airò P, Bazzani C, Beindorf EA, Berlendis M, Bezzi M, Bossini N, Castellano M, Cattaneo S, Cavazzana I, Contessi GB, Crippa M, Delbarba A, De Peri E, Faletti A, Filippini M, Filippini M, Frassi M, Gaggiotti M, Gorla R, Lanspa M, Lorenzotti S, Marino R, Maroldi R, Metra M, Matteelli A, Modina D, Moioli G, Montani G, Muiesan ML, Odolini S, Peli E, Pesenti S, Pezzoli MC, Pirola I, Pozzi A, Proto A, Rasulo FA, Renisi G, Ricci C, Rizzoni D, Romanelli G, Rossi M, Salvetti M, Scolari F, Signorini L, Taglietti M, Tomasoni G, Tomasoni LR, Turla F, Valsecchi A, Zani D, Zuccalà F, Zunica F, Focà E, Andreoli L, Latronico N. Tocilizumab for the treatment of severe COVID-19 pneumonia with hyperinflammatory syndrome and acute respiratory failure: a single center study of 100 patients in Brescia, Italy. Autoimmun Rev. 2020;19(7):102568 Epub 2020 May 3.CrossRefPubMed

go back to reference Bersanelli M. Controversies about COVID-19 and anticancer treatment with immune checkpoint inhibitors. Immunotherapy. 2020;12(5):269–73. Epub 2020 Mar 26.CrossRefPubMed Bersanelli M. Controversies about COVID-19 and anticancer treatment with immune checkpoint inhibitors. Immunotherapy. 2020;12(5):269–73. Epub 2020 Mar 26.CrossRefPubMed